As their prevalence within the global healthcare logistics industry grows, medical drones could be clearing the way for drone deliveries of all kinds.
With the acquisition of biotech start-up Peloton Therapeutics, Merck will strengthen its portfolio as well as its position in oncology immunotherapy.
Lower volumes, higher biotech industry costs, and the departure of big pharmaceutical companies from the field thwart development of new antibiotics.
Continuing to execute on its new R&D strategy, GlaxoSmithKline has agreed to buy the rights to a next-generation cancer immunotherapy from Merck.
By merging with Celgene in a record $74 billion deal, Bristol-Meyers will create a formidable organization in the competitive immunotherapy space.
Takeda finally has approval to acquire another large firm, Ireland-based Shire, for $56 billion in the biggest-ever foreign takeover by a Japanese firm.
Boyden's Steve Nilsen interviews David Kerwar, Chief Product Officer and Head of Consumer Digital Innovations at Mount Sinai Health System, as one the country’s leading health systems embraces digital.
Our discussion with Ray Pisani, President & CEO of Alberta Blue Cross on leadership, motivation, and the value of diversity.
Boyden UK's Industrial Team recently attended the Manufacturing Leaders Summit as part of Digital Manufacturing Week and people have consistently been highlighted as the key to future success.
